Quelles nouveautés en antibiothérapie ?
- 31 March 2010
- journal article
- review article
- Published by Elsevier in Medecine Et Maladies Infectieuses
- Vol. 40 (3), 135-154
- https://doi.org/10.1016/j.medmal.2009.10.009
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Activity of Temocillin against KPC-Producing Klebsiella pneumoniae and Escherichia coliAntimicrobial Agents and Chemotherapy, 2009
- Potency and Bactericidal Activity of Iclaprim against Recent Clinical Gram-Positive IsolatesAntimicrobial Agents and Chemotherapy, 2009
- Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin® Outcomes Registry and Experience (CORE)International Journal of Antimicrobial Agents, 2009
- In Vitro Activity of Ceftobiprole against Pathogens from Two Phase 3 Clinical Trials of Complicated Skin and Skin Structure InfectionsAntimicrobial Agents and Chemotherapy, 2008
- In vitro activity of ceftobiprole, linezolid, tigecycline, and 23 other antimicrobial agents against Staphylococcus aureus isolates in ChinaDiagnostic Microbiology and Infectious Disease, 2008
- In Vitro Activity of Telavancin against Resistant Gram-Positive BacteriaAntimicrobial Agents and Chemotherapy, 2008
- Occurrence of Tetracycline Resistance Genes among Escherichia coli Isolates from the Phase 3 Clinical Trials for TigecyclineAntimicrobial Agents and Chemotherapy, 2007
- In Vitro Activities of Dalbavancin and 12 Other Agents against 329 Aerobic and Anaerobic Gram-Positive Isolates Recovered from Diabetic Foot InfectionsAntimicrobial Agents and Chemotherapy, 2006
- The Cfr rRNA Methyltransferase Confers Resistance to Phenicols, Lincosamides, Oxazolidinones, Pleuromutilins, and Streptogramin A AntibioticsAntimicrobial Agents and Chemotherapy, 2006
- Quinupristin/DalfopristinDrugs, 1999